<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao Y</submitter><funding>Key Technologies Research and Development Program</funding><funding>Science and Technology Development Fund</funding><funding>National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><funding>Suzhou Applied Basic Research (Healthcare) Science and Technology Innovation Program</funding><funding>National Key Research and Development Program of China</funding><pagination>e2416330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12021062</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(16)</volume><pubmed_abstract>Current diagnostics for sepsis-associated acute kidney injury (SA-AKI) detect kidney damage only at advanced stages, limiting opportunities for timely intervention. A DNA origami-based nanoplatform is developed for the early diagnosis and treatment of SA-AKI. Modified with a fluorophore (Cy5) and quencher (BHQ3), the DNA origami remains nonfluorescent under normal conditions. During SA-AKI, elevated microRNA-21 triggers a strand displacement reaction that restores the fluorescence signal, enabling real-time detection. Additionally, the photoacoustic changes of BHQ3, driven by different excretion rates of the nanostructure and released DNA strands, enable dual-mode imaging, enhancing diagnostic accuracy. Therapeutically, DNA origami scavenges reactive oxygen species and, when conjugated wit</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>A Dual-Response DNA Origami Platform for Imaging and Treatment of Sepsis-Associated Acute Kidney Injury.</pubmed_title><pmcid>PMC12021062</pmcid><funding_grant_id>2024M762281</funding_grant_id><funding_grant_id>SYW2024068</funding_grant_id><funding_grant_id>2023YFB3208200</funding_grant_id><funding_grant_id>0002/2022/AKP</funding_grant_id><funding_grant_id>0115/2023/RIA2</funding_grant_id><funding_grant_id>21825402</funding_grant_id><funding_grant_id>22074101</funding_grant_id><funding_grant_id>22393932</funding_grant_id><pubmed_authors>Dong F</pubmed_authors><pubmed_authors>Ling Y</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Dual-Response DNA Origami Platform for Imaging and Treatment of Sepsis-Associated Acute Kidney Injury.</name><description>Current diagnostics for sepsis-associated acute kidney injury (SA-AKI) detect kidney damage only at advanced stages, limiting opportunities for timely intervention. A DNA origami-based nanoplatform is developed for the early diagnosis and treatment of SA-AKI. Modified with a fluorophore (Cy5) and quencher (BHQ3), the DNA origami remains nonfluorescent under normal conditions. During SA-AKI, elevated microRNA-21 triggers a strand displacement reaction that restores the fluorescence signal, enabling real-time detection. Additionally, the photoacoustic changes of BHQ3, driven by different excretion rates of the nanostructure and released DNA strands, enable dual-mode imaging, enhancing diagnostic accuracy. Therapeutically, DNA origami scavenges reactive oxygen species and, when conjugated wit</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-05-29T17:11:57.536Z</modification><creation>2025-06-26T03:05:27.268Z</creation></dates><accession>S-EPMC12021062</accession><cross_references><pubmed>40019357</pubmed><doi>10.1002/advs.202416330</doi></cross_references></HashMap>